fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Sulfamethoxazole & trimethoprim

All products: general benefit

Teva-Trimel · DIN 00726540 · 40 mg & 8 mg/mL · oral liquid

General benefitDormant since May 14, 2021 · checked October 5, 2026 · What does dormant mean?
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗) Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗) The Special Drugs Program will cover costs for the above drugs if the patient: is an Ontario resident has a valid Ontario Health Insurance (OHIP) has one of the diseases or conditions covered meets the established clinical criteria is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Teva-Trimel · DIN 00726540 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $1.0260 Health Canada: Dormant since 2021-05-14 · brand TEVA-TRIMEL · ATC J01EE01 SULFAMETHOXAZOLE AND TRIMETHOPRIM · form Suspension · route Oral · ingredients TRIMETHOPRIM 8 MG/ML, SULFAMETHOXAZOLE 40 MG/ML · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Teva-Trimel: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.1026). What the ministry pays, not the patient.

Ministry pays: $0.1026 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00726540)

Source record
DIN 00726540: Teva-Trimel Raw flags: sec3=Y Item: 084000002; group id 139; item number 0232; lccId None; manufacturer id TEV Source form: O/L; strength: 40mg & 8mg/mL Recorded listing: General benefit Source prices (unrounded): $0.1026; ministry $0.1026 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00726540 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=7313
Interchangeable products
Bactrim Sugar Free · DIN 00272485 · not recorded Septra · DIN 00270644 · not recorded
Shortage status: active shortage (reported February 1, 2017, last updated October 13, 2017) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00726540
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since May 14, 2021 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (J01E): coverage varies; not interchangeable

  • Trimethoprim (Proloprim): general benefit, not a benefit
Other drugs in the same formulary class (08:40 Miscellaneous Anti-Infectives) and how they are covered

Matched class: 08:40 Miscellaneous Anti-Infectives

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): CIPROFLOXACIN, LEVOFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, NORFLOXACIN, TRIMETHOPRIM 08:40 Miscellaneous Anti-Infectives

TRIMETHOPRIM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 100mg, 200mg · Tab

CIPROFLOXACIN

· 44 products · Limited Use, codes 533 (1), Listed, not a benefit (3), General benefit (40) · strengths: 10g/100mL, 250mg, 500mg, 750mg · Oral Susp, Tab

LEVOFLOXACIN

· 24 products · Listed, not a benefit (2), General benefit (14), Off-Formulary Interchangeable, not an ODB benefit (8) · strengths: 250mg, 500mg, 750mg · Tab

MOXIFLOXACIN HYDROCHLORIDE

· 12 products · Listed, not a benefit (1), General benefit (11) · strengths: 400mg · Tab

NORFLOXACIN

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 400mg · Tab

CIPROFLOXACIN HCL & CIPROFLOXACIN BASE

· 2 products · Listed, not a benefit (1), Limited Use, codes 394 (1) · strengths: 500mg · ER Tab

LINEZOLID

· 7 products · Off-Formulary Interchangeable, not an ODB benefit (3), Listed, not a benefit (1), Limited Use, codes 362, 363, 364 (3) · strengths: 2mg/mL, 600mg · Inj-300mL Pk, Tab

CEFEPIME

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1g, 2g · Inj Pd-Vial Pk

ERTAPENEM

· 5 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1g/Vial · Inj Pd-Vial Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 08:40
Full class listing Related classes: 08:08 Anthelmintics, 08:12 Antibiotics, 08:14 Antifungals, 08:16 Antitubercular Agents, 08:18 Antivirals, 08:20 Plasmodicides (Antimalarials), 08:24 Sulfonamides, 08:30 Antiprotozoals, 08:32 Trichomonacides, 08:36 Urinary Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1. Indications SULFATRIM (sulfamethoxazole and trimethoprim tablets) is indicated for treatment of infections associated with the following gram-positive and gram-negative organisms: Gram-Negative Organisms Haemophilus influenzae Neisseria gonorrhoeae Escherichia coli Klebsiella species Enterobacter (Aerobacter) aerogenes Proteus mirabilis Proteus vulgaris Salmonella species Shigella species Vibrio cholerae Gram-Positive Organisms Streptococcus pyogenes Streptococcus viridans Staphylococcus albus Staphylococcus aureus Diplococcus pneumoniae Other Organisms Brucella melitensis Nocardia asteroides Nocardia brasiliensis Paracoccidioides brasiliensis Pneumocystis jiroveci Streptomyces somaliensis Sensitivity tests should be performed wherever possible to determine choice of therapy. These tests should be repeated if there is a failure to respond, relapse or early recurrence. SULFATRIM may be indicated for the following infections when caused by susceptible strains of the above organisms. Urinary Tract Infections: Treatment of acute uncomplicated urinary tract infections*. It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single e… https://pdf.hres.ca/dpd_pm/00085471.PDF PM date: not printed or not captured Source product: SULFATRIM; DIN 00445274; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Teva-Trimel · DIN 00726540 Shortage status: active shortage (reported 2017-02-01, last updated 2017-10-13) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00726540

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, September 10, 2026 ↗)